Prostate Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a specific type of prostate cancer (adenocarcinoma of the prostate) confirmed by a tissue or cell sample, without certain rare cell types present.
• People whose cancer has spread (metastasised) to at least one other part of the body, as seen on a bone scan, CT scan, MRI, or certain specialised imaging scans.
• People aged 65 years or older.
• People who are about to start an intensified hormone-blocking treatment plan that combines two specific types of hormone therapy (ADT and ARSI).
• People who are able to understand the study and are willing to sign a written consent form.

Who may not be able to join:

• People who have previously received hormone-blocking therapy (ADT or ARSI) within 12 months of their diagnosis, unless that treatment was started within 12 weeks of enrolling in the trial.
• People who had surgical removal of the testicles more than 12 weeks before their metastatic cancer diagnosis.
• People who have previously received chemotherapy for metastatic prostate cancer.
• People who have another illness that is not well controlled or stable at the time of enrolment, such as poorly managed diabetes or high blood pressure (confirm with trial site).
• People who have a specific rare type of prostate cancer called small-cell carcinoma, or who have cancer that has spread to the brain.
• People who are not able to read and write in English or Spanish.
• People who are pregnant or are not biological males, as this trial is specifically for prostate cancer in biological males.
• People who have an implanted cardiac (heart) device, such as a pacemaker.
• People who have a limb difference or condition that would prevent them from wearing a smartwatch.

Important: Always verify eligibility with the trial site directly before applying.